Dr. Ahmed Lasfar is a member of the Cancer Institute of New Jersey, a principal investigator and a faculty member at Ernest Mario School of Pharmacy, Rutgers University, New Jersey. Dr. Lasfar is an innovator and a scientific adviser for pharmaceutical industry. He is an editor, a board member, and a reviewer of several international journals. He is often invited as a speaker for conferences on cancer, immunology and pharmaceuticals. He graduated in France from Paris Rene Descartes University on medical and applied science. He completed his doctoral studies in Immunology at Paris Diderot University and his postdoctoral training in cancer immunology at Robert Wood Johnson Medical School, New Jersey. His research interests involve hematological malignancies, breast cancer, liver cancer and melanoma. His laboratory is more focused on cancer immunology and the elucidation of the mechanisms of cancer metastasis. He published breakthrough articles and holds patents for developing new drugs in oncology and infectious diseases.